The Competition Tribunal has unconditionally approved the proposed merger in which RMB Ventures Nine (Pty) Ltd (“RMBV Nine”) will acquire shares in Vertium Bio (Pty) Ltd (“Vertium”).
 
The primary acquiring firm is RMBV Nine, a private equity investor focused on investing in established South African businesses. The acquiring group (the acquiring firm, all entities that control the acquiring firm as well as all entities controlled by the acquiring firm) operates in the South African financial sector offering retail, commercial, corporate and investment banking services.
 
The target firm, Vertium, is a newly formed holding company with no business activities. It operates through its two wholly owned subsidiaries in South Africa. One of these subsidiaries is engaged in the manufacture and supply of biological agricultural products in South Africa.